Status:

WITHDRAWN

Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy

Lead Sponsor:

Amgen

Conditions:

Severe Aplastic Anemia (SAA)

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Romiplostim has been used in clinical trials for the treatment of severe and very severe aplastic anemia (SAA/vSAA) in Asian participants who are either previously untreated with immunosuppressive the...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years at time of enrollment
  • Diagnosis of SAA/vSAA confirmed by blood, bone marrow, and cytogenetic studies
  • An Eastern Cooperative Oncology Group (ECOG) performance status score of 0 to 1 at screening
  • Arm 1 only: participant requires initial treatment for SAA/vSAA, no matched related donor is available for allogenic hematopoietic cell transplantation (HCT) and will begin IST with antithymocyte globulin and CsA
  • Arm 2 only: refractory to at least one course of immunosuppressive therapy including horse or rabbit ATG; or ineligible for ATG treatment and refractory to CsA

Exclusion

  • Diagnosed as having congenital aplastic anemia (AA) (Fanconi anemia, congenital dyskeratosis, etc)
  • History of other malignancy within the past 5 years, with exceptions.
  • Aplastic anemia with hemolytic paroxysmal nocturnal hemoglobinuria (PNH) (hemolytic predominant is defined as lactate dehydrogenase (LDH) \> 1.5 x the upper limit of site normal
  • Arm 1 only: Previously treated with ATG, CsA, or Alemtuzumab
  • Previously treated with PEGylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF), recombinant human thrombopoietin protein (TPO), romiplostim and other TPO-receptor agonist (eltrombopag, etc)
  • Patients who are eligible for allogenic HCT and have an available matched related donor

Key Trial Info

Start Date :

August 31 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 25 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05323617

Start Date

August 31 2023

End Date

February 25 2025

Last Update

September 29 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.